Academic Journal
Neurodegenerative Diseases: The Value of Early Predictive End Points
| Τίτλος: | Neurodegenerative Diseases: The Value of Early Predictive End Points |
|---|---|
| Συγγραφείς: | Janicki Hsieh, Sarah, Alexopoulou, Zoi, Mehrotra, Nitin, Struyk, Arie, Stoch, S. Aubrey |
| Πηγή: | Clinical Pharmacology & Therapeutics ; volume 111, issue 4, page 835-839 ; ISSN 0009-9236 1532-6535 |
| Στοιχεία εκδότη: | Wiley |
| Έτος έκδοσης: | 2022 |
| Συλλογή: | Wiley Online Library (Open Access Articles via Crossref) |
| Περιγραφή: | Use of early predictive biomarkers of neurodegenerative disease in phase I clinical trials may improve the translation of novel drug therapies from preclinical development through late‐stage studies. This article provides a categorical summary of promising biomarker approaches or clinical end points in molecular, cellular, metabolic, electrophysiological, or clinical function that can be used to predict or quantify the progression of neurodegenerative disorders and guide program support. |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| DOI: | 10.1002/cpt.2544 |
| Διαθεσιμότητα: | https://doi.org/10.1002/cpt.2544 https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2544 https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.2544 https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2544 |
| Rights: | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| Αριθμός Καταχώρησης: | edsbas.F0F995E9 |
| Βάση Δεδομένων: | BASE |
| DOI: | 10.1002/cpt.2544 |
|---|